GlassScriptPhysician profile
Donald D Fraser
NPI 1508861105
$3,084.59
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,182 · 2020: $902.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $837.06 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $363.93 | 2019-2020 | |
| Janssen Biotech, INC. | $337.56 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $282.65 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $258.69 | 2019-2020 | |
| Celgene Corporation | $123.96 | 2019 | |
| Amgen INC. | $112.38 | 2019-2020 | |
| Genzyme Corporation | $111.14 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $108.42 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $87.48 | 2019 | |
| Medimetriks Pharmaceuticals, INC. | $71.28 | 2019 | |
| Dermira, INC. | $65.37 | 2019-2020 | |
| Pfizer INC. | $57.18 | 2019-2020 | |
| Almirall LLC | $50.70 | 2019-2020 | |
| Galderma Laboratories, L.P. | $49.18 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $47.67 | 2019-2020 | |
| Vyne Pharmaceuticals INC. | $37.05 | 2020 | |
| Ucb, INC. | $36.19 | 2019-2020 | |
| Journey Medical Corporation | $35.47 | 2019 | |
| Leo Pharma INC. | $11.23 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Fraser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.